author = { World Bank },

title = { A Generic Drug Policy as Cornerstone to Essential Medicines in China },

publisher = {},

keywords = { ACCESS TO HEALTH CARE , ACCESS TO INFORMATION , ACTIVE INGREDIENTS , AGING , ANTIBIOTICS , BENCHMARKS , BIDDING , BIOEQUIVALENCE , CANCER , CAPACITY BUILDING , CAPITATION , CAPITATION BASIS , CENTER FOR HEALTH , CERTIFICATION , CHRONIC CONDITIONS , CHRONIC DISEASES , CITIZEN , CITIZENS , CLINICAL GUIDELINES , CLINICAL PRACTICE , COMMUNITY HEALTH , CONSUMER EDUCATION , COOPERATIVE MEDICAL INSURANCE , DECISION MAKING , DEVELOPING COUNTRIES , DIABETES , DIAGNOSIS , DIFFERENTIAL PRICING , DISSEMINATION , DISTRIBUTION SYSTEMS , DOCTORS , DOSAGES , DRUG ADMINISTRATION , DRUG INDUSTRY , DRUG LIST , DRUG MARKETS , DRUG POLICIES , DRUG PRICES , DRUG UTILIZATION , DRUGS , ECONOMIC IMPLICATIONS , ECONOMIC PROGRESS , EQUAL ACCESS , EQUITABLE ACCESS , ESSENTIAL DRUGS , ESSENTIAL MEDICINES , FAMILIES , FEES FOR SERVICES , FINANCIAL COMMITMENT , FORECASTS , FRAUD , GENERIC DRUGS , GMP , GOOD MANUFACTURING PRACTICES , GOVERNMENT AGENCIES , GROSS DOMESTIC PRODUCT , HEALTH AUTHORITIES , HEALTH CARE , HEALTH CARE COVERAGE , HEALTH CARE SYSTEM , HEALTH CENTERS , HEALTH COVERAGE , HEALTH ECONOMICS , HEALTH EXPENDITURE , HEALTH EXPENDITURES , HEALTH FACILITIES , HEALTH IMPACT , HEALTH INSTITUTIONS , HEALTH INSURANCE , HEALTH MAINTENANCE ORGANIZATIONS , HEALTH OUTCOMES , HEALTH POLICY , HEALTH PROFESSIONALS , HEALTH PROVIDERS , HEALTH REFORM , HEALTH REFORMS , HEALTH RISKS , HEALTH SECTOR , HEALTH SECTOR REFORM , HEALTH SERVICE , HEALTH SERVICES , HEALTH STATUS , HEALTH STRATEGIES , HEALTH SYSTEM , HEALTHCARE , HEPATITIS B , HIV/AIDS , HOSPITAL , HOSPITAL PHARMACIES , HOSPITALS , HUMAN RESOURCES , HYPERTENSION , ILLNESSES , INCOME , INFECTIOUS DISEASES , INSURANCE COVERAGE , INSURANCE SCHEMES , INSURERS , INTERFERON , INTERMEDIARIES , INTERVENTION , IRRATIONAL USE , LACK OF INFORMATION , LARGE NUMBERS OF PEOPLE , LARGE POPULATIONS , LIVING STANDARDS , MANAGEMENT SYSTEMS , MARKETING , MEDICAL CARE , MEDICAL CONDITIONS , MEDICAL EDUCATION , MEDICAL INSURANCE , MEDICAL SERVICES , MEDICAL STAFF , MEDICAL SYSTEMS , MEDICAL TECHNOLOGIES , MEDICATION , MEDICINE , MEDICINES , MIGRANT , MINISTRY OF HEALTH , MORTALITY , NATIONAL DEVELOPMENT , NATIONAL DRUG , NATIONAL HEALTH SYSTEM , NATIONAL LEVEL , NATIONAL LEVELS , NDP , NURSES , NUTRITION , PACKAGING , PATIENT , PATIENT EDUCATION , PATIENTS , PERSONAL RELATIONSHIPS , PHARMACEUTICAL , PHARMACEUTICAL DISTRIBUTION , PHARMACEUTICAL EXPENDITURE , PHARMACEUTICAL INDUSTRY , PHARMACEUTICAL MANUFACTURERS , PHARMACEUTICAL POLICY , PHARMACEUTICAL PRICES , PHARMACEUTICAL REFORM , PHARMACEUTICAL SECTOR , PHARMACEUTICAL SUPPLIERS , PHARMACEUTICAL SUPPLY , PHARMACEUTICALS , PHARMACISTS , PHARMACY , PHYSICIAN , PHYSICIANS , POOLED PROCUREMENT , POOR FAMILIES , PRESCRIPTIONS , PRIMARY CARE , PRIVATE HEALTH INSURANCE , PROGRESS , PROVIDER PAYMENT , PUBLIC EDUCATION , PUBLIC HEALTH , PUBLIC HEALTH INSURANCE , PUBLIC HOSPITALS , PURCHASING , PURCHASING POWER , QUALITY ASSURANCE , QUALITY OF CARE , QUALITY OF SERVICES , RATES OF GROWTH , RATIONAL DRUG USE , RATIONAL USE OF DRUGS , REFORM EFFORT , REGULATORY AUTHORITIES , REMEDIES , RESPECT , RETAIL PHARMACIES , RURAL AREAS , RURAL POPULATION , RURAL RESIDENTS , SERVICE CONTRACTS , SERVICE PROVIDER , SERVICE PROVIDERS , SOCIAL HEALTH INSURANCE , SOCIAL SECURITY , SOCIAL WELFARE , STATE PLANNING , THERAPIES , TRADITIONAL MEDICINES , TREATMENT GUIDELINES , TREATMENTS , URBAN AREAS , URBAN ENVIRONMENTS , URBAN POPULATIONS , USER FEES , WASTE , WORKERS , WORLD HEALTH ORGANIZATION },

year = {2010},

abstract = {China},

abstract = {East Asia and Pacific},

booktitle = {China Health Policy Notes ; No. 4},

address = { Washington, DC },

url = { http://slubdd.de/katalog?TN_libero_mab2 }